Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Mar-24 4:33 PM View:  | Nkarta, Inc. (NKTX) | 04-Mar-24 | Disposition | 137,642 | $13.33 | $1,834,770.00 | (36%) 378.15K to 240.51K | |
| 05-Mar-24 4:33 PM View: | Nkarta, Inc. (NKTX) | 01-Mar-24 | Disposition | 12,358 | $13.00 | $160,654.00 | (3%) 390.51K to 378.15K | |
| 18-Jan-24 4:40 PM View: | Nkarta, Inc. (NKTX) | 16-Jan-24 | Sale | 9,697 | $8.74 | $84,751.80 | (2%) 400.2K to 390.51K | |
| 08-Jan-24 4:47 PM View: | Nkarta, Inc. (NKTX) | 04-Jan-24 | Grant | 85,000 | -- | -- | 27% 315.2K to 400.2K | |
| 22-Jun-23 4:20 PM View: | Nkarta, Inc. (NKTX) | 20-Jun-23 | Sale | 1,704 | $4.85 | $8,264.40 | (< 1%) 315.11K to 313.4K | |
| 07-Jun-23 9:23 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jun-23 | Sale | 580 | $38.34 | $22,236.60 | (8%) 7.18K to 6.6K | |
| 17-May-23 4:07 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-May-23 | Option Exercise | 7,000 | $29.90 | $209,300.00 | 98% 7.18K to 14.18K | |
| 17-May-23 4:07 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-May-23 | Planned Option Sale | 7,000 | $41.85 | $292,950.00 | (49%) 14.18K to 7.18K | |
| 18-Jan-23 7:04 PM View: | Nkarta, Inc. (NKTX) | 17-Jan-23 | Sale | 3,691 | $5.49 | $20,263.60 | (1%) 316.8K to 313.11K | |
| 18-Jan-23 7:04 PM View: | Nkarta, Inc. (NKTX) | 13-Jan-23 | Grant | 64,500 | -- | -- | 26% 252.3K to 316.8K | |
| 30-Sep-22 4:30 PM View: | Nkarta, Inc. (NKTX) | 29-Sep-22 | Sale (Planned) | 498 | $13.00 | $6,474.00 | (< 1%) 250.96K to 250.46K | |
| 30-Sep-22 4:30 PM View: | Nkarta, Inc. (NKTX) | 28-Sep-22 | Sale (Planned) | 23,376 | $13.03 | $304,615.00 | (9%) 274.33K to 250.96K | |
| 22-Sep-22 5:32 PM View: | Nkarta, Inc. (NKTX) | 21-Sep-22 | Sale (Planned) | 6,126 | $13.01 | $79,717.00 | (2%) 280.46K to 274.33K | |
| 13-Jul-22 4:03 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 11-Jul-22 | Market Sale (Planned) | 533 | $56.95 | $30,354.30 | (7%) 7.71K to 7.18K | (8%) |
| 21-Jun-22 7:11 PM View: | Nkarta, Inc. (NKTX) | 17-Jun-22 | Grant | 19,500 | -- | -- | 7% 260.96K to 280.46K | |
| 08-Jun-22 7:28 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Jun-22 | Grant | 1,160 | -- | -- | 18% 6.55K to 7.71K | |
| 19-Jan-22 4:53 PM View: | Nkarta, Inc. (NKTX) | 14-Jan-22 | Grant | 41,900 | -- | -- | 19% 219.06K to 260.96K | |
| 01-Oct-21 4:35 PM View: | Nkarta, Inc. (NKTX) | 29-Sep-21 | Market Sale (Planned) | 8,500 | $27.18 | $231,051.00 | (4%) 227.56K to 219.06K | (2%) |
| 23-Jun-21 4:05 PM View: | Nkarta, Inc. (NKTX) | 21-Jun-21 | Market Sale (Planned) | 8,500 | $26.61 | $226,218.00 | (4%) 236.06K to 227.56K | (2%) |
| 11-Jun-21 8:33 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-Jun-21 | Grant | 1,066 | -- | -- | 19% 5.49K to 6.55K | |
| 08-Jun-21 4:13 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Jun-21 | Market Sale (Planned) | 630 | $62.19 | $39,179.70 | (10%) 6.12K to 5.49K | < 1% |
| 01-Apr-21 6:15 AM View: | Nkarta, Inc. (NKTX) | 30-Mar-21 | Market Sale (Planned) | 17,000 | $30.74 | $522,540.00 | (7%) 253.06K to 236.06K | |
| 09-Mar-21 4:12 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Mar-21 | Option Exercise | 3,000 | $13.98 | $41,940.00 | 49% 6.12K to 9.12K | |
| 09-Mar-21 4:12 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Mar-21 | Market Option Sale | 3,000 | $65.88 | $197,640.00 | (33%) 9.12K to 6.12K | |
| 11-Jun-20 6:24 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-Jun-20 | Grant | 1,260 | -- | -- | 26% 4.86K to 6.12K | |
| 08-Jun-20 9:05 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Jun-20 | Market Sale | 2,025 | $47.46 | $96,106.50 | (29%) 6.88K to 4.86K | (25%) |
| 06-Jun-19 4:39 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jun-19 | Grant | 4,134 | -- | -- | 150% 2.75K to 6.88K | |
| 06-Jun-19 4:39 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Jun-19 | Market Sale (Planned) | 782 | $42.66 | $33,360.10 | (22%) 3.53K to 2.75K | (39%) |
| 15-Jun-18 7:14 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 13-Jun-18 | Grant | 782 | -- | -- | 28% 2.75K to 3.53K | |
| 06-Jun-18 8:07 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Jun-18 | Market Sale | 771 | $33.90 | $26,136.90 | (22%) 3.52K to 2.75K | (75%) |
| 12-Oct-17 6:35 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 10-Oct-17 | Market Sale | 1,398 | $4.24 | $5,931.04 | (< 1%) 402.43K to 401.03K | 78% |
| 24-Aug-17 8:30 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 22-Aug-17 | Market Sale | 1,044 | $36.15 | $37,740.60 | (23%) 4.56K to 3.52K | (64%) |
| 16-Jun-17 8:14 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 14-Jun-17 | Grant | 1,357 | -- | -- | 42% 3.21K to 4.56K | |
| 25-Apr-17 6:12 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 24-Apr-17 | Grant | 45,000 | -- | -- | 13% 357.43K to 402.43K | |
| 05-Apr-17 7:38 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 04-Apr-17 | Market Sale | 6,473 | $9.06 | $58,624.60 | (2%) 363.9K to 357.43K | 90% |
| 09-Jan-17 5:55 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 06-Jan-17 | Option Exercise | 21,369 | $1.43 | $30,557.70 | 6% 362.16K to 383.53K | |
| 09-Jan-17 5:55 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 06-Jan-17 | Market Option Sale (Planned) | 21,369 | $8.52 | $181,957.00 | (6%) 383.53K to 362.16K | 89% |
| 09-Jan-17 5:55 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 05-Jan-17 | Option Exercise | 21,369 | $1.43 | $30,557.70 | 6% 362.16K to 383.53K | |
| 09-Jan-17 5:55 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 05-Jan-17 | Market Option Sale (Planned) | 21,369 | $8.17 | $174,602.00 | (6%) 383.53K to 362.16K | 89% |
| 11-Oct-16 9:43 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 09-Oct-16 | Grant | 14,000 | -- | -- | 4% 348.16K to 362.16K | |
| 02-Sep-16 12:34 PM View: | Relypsa Inc (RLYP) | 01-Sep-16 | Disposition | 2,250 | $32.00 | $72,000.00 | (47%) 4.75K to 2.5K | |
| 02-Sep-16 12:34 PM View: | Relypsa Inc (RLYP) | 01-Sep-16 | Disposition (change in control) | 2,495 | $32.00 | $79,840.00 | (100%) 2.5K to 0 | |
| 23-Jun-16 5:55 PM View: | Relypsa Inc (RLYP) | 21-Jun-16 | Grant | 2,250 | -- | -- | 90% 2.5K to 4.75K | |
| 17-Jun-16 4:51 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Jun-16 | Grant | 1,488 | -- | -- | 87% 1.72K to 3.21K | |
| 08-Jun-16 5:18 PM View: | Relypsa Inc (RLYP) | 07-Jun-16 | Market Sale | 1,013 | $19.32 | $19,573.00 | (29%) 3.51K to 2.5K | (< 1%) |
| 08-Jun-16 7:02 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-16 | Market Sale (Planned) | 1,136 | $46.95 | $53,335.20 | (40%) 2.85K to 1.72K | (26%) |
| 22-Feb-16 7:38 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 17-Feb-16 | Option Exercise | 3,000 | $12.92 | $38,770.00 | 105% 2.85K to 5.85K | |
| 22-Feb-16 7:38 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 17-Feb-16 | Market Option Sale (Planned) | 3,000 | $60.00 | $180,000.00 | (51%) 5.85K to 2.85K | 1% |
| 08-Jan-16 7:25 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 06-Jan-16 | Market Sale | 2,412 | $22.28 | $53,730.70 | (< 1%) 349.28K to 346.87K | 96% |
| 24-Nov-15 6:32 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 20-Nov-15 | Option Exercise | 3,000 | $10.81 | $32,430.00 | 105% 2.85K to 5.85K |